✉ Email this page to a colleague
« Back to Dashboard
L-Phenylalanine is an investigational drug.
There have been 104 clinical trials for L-Phenylalanine. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2001.
The most common disease conditions in clinical trials are Multiple Myeloma, Neoplasms, Plasma Cell, and Lymphoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Fred Hutchinson Cancer Research Center, and M.D. Anderson Cancer Center.
Recent Clinical Trials for L-Phenylalanine
|Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome||Children's Oncology Group||Phase 3|
|A Study to Give Treatment Inside the Eye to Treat Retinoblastoma||Children's Oncology Group||Phase 2|
|Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma||ADC Therapeutics||Phase 1|